Dahlof, B., Devereux, R.B., Kjeldsen, S.E., Julius, S., Beevers, G., de Faire, U., Fyhrquist, F., Ibsen, H., Kristiansson, K., Lederballe-Pedersen, O., Lindholm, L.H., Nieminen, M.S., Omvik, P., Oparil, S. and Wedel, H. (2002) Cardiovascular Morbidity and Mortality in the Losartan Intervention for Endpoint Reduction in Hypertension Study (LIFE): A Randomised Trial against Atenolol. The Lancet, 359, 995-1003.
http://dx.doi.org/10.1016/S0140-6736(02)08089-3

has been cited by the following article:

• TITLE: Prevalence and Characteristics of Treatment-Resistant Hypertension among Hypertensive Japanese Outpatients

  AUTHORS: Keisuke Okamura, Hidenori Urata

  KEYWORDS: Treatment-Resistant Hypertension, Catheter-Based Renal Sympathetic Denervation, Human

  JOURNAL NAME: International Journal of Clinical Medicine, Vol.6 No.9, September 10, 2015

  ABSTRACT: Aims: To retrospectively investigate the prevalence and characteristics of treatment-resistant hypertension (R-HT) among consecutive hypertensive outpatients, since patients with R-HT are candidates for catheter-based renal sympathetic denervation (RD). Methods: Consecutive hypertensive outpatients (n = 999) were recruited in our hospital. R-HT patients who were candidates for RD had clinic systolic blood pressure > 160 mmHg despite taking three or more antihypertensive drugs including at least one diuretics at higher than standard doses. Results: Our survey indicated that only 26 patients (2.6%) were potential candidates for renal denervation. Candidates for RD showed a significantly higher age (P